• Atrys Health will hold an extraordinary shareholders’ meeting on November 27, 2026, at CaixaBank’s offices in Madrid.
• A second-call meeting is scheduled for November 30, 2026, at the same venue if needed.
• Shareholders will vote on amendments to the board’s authorization to issue up to EUR 25 million in convertible bonds and similar securities.
• The authorization granted on December 21, 2023, runs for a maximum of five years; its remaining conditions would stay unchanged.
• The agenda also includes reelecting Jaime Cano Fernández as an independent director for a four-year term.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atrys Health SA published the original content used to generate this news brief on October 23, 2026, and is solely responsible for the information contained therein.